CTCX יחס מהיר Carmell Corporation

Carmell Corporation (CTCX) operates in the field of tissue regeneration, facing threats due to a lack of profitability, dependence on patents, and the early stages of drug implementation. The asset's market value, which currently stands at 0.68 as illustrated on this chart, is supplemented by the implementation of eco-friendly synthesis methods and the reduction of transport emissions. Business resilience is ensured by a unique base of plasma materials, which creates significant barriers for traditional treatments.

Quick liquidity determines an issuer's ability to settle short-term debts relying exclusively on highly liquid assets. The speed of covering current liabilities demonstrates the balance of cash and accounts receivable, excluding slow-moving inventory. This calculation excludes illiquid goods, revealing the actual financial stability of the structure. For Carmell Corporation (CTCX), this reserve is critical during the period of business model transformation and the search for new drivers to commercialize cosmetic lines.